tiprankstipranks
Editas Medicine Inc (EDIT)
NASDAQ:EDIT

Editas Medicine (EDIT) Similar Stocks

Compare
3,395 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Editas Medicine
$2.06
$170.05M
-74.02%
4 Buy
9 Hold
2 Sell
Hold
Sangamo Biosciences
$1.12
$239.94M
-9.68%
5 Buy
1 Hold
0 Sell
Strong Buy
Bluebird Bio
$7.04
$68.44M
-70.17%
1 Buy
4 Hold
0 Sell
Hold
Intellia Therapeutics
$12.25
$1.17B
-54.43%
11 Buy
2 Hold
0 Sell
Strong Buy
Crispr Therapeutics AG
$50.43
$4.48B
-41.49%
12 Buy
8 Hold
1 Sell
Moderate Buy
Beam Therapeutics
$33.14
$2.77B
4.35%
11 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
EDIT
Editas Medicine
2.06
-5.87
-74.02%
SGMO
Sangamo Biosciences
1.12
0.02
1.82%
BLUE
Bluebird Bio
7.04
-16.56
-70.17%
NTLA
Intellia Therapeutics
12.25
-14.93
-54.93%
CRSP
Crispr Therapeutics AG
50.43
-35.76
-41.49%
BEAM
Beam Therapeutics
33.14
-0.40
-1.19%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis